D. E. Shaw & Co., Inc. - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$5,658,511
-55.2%
549,370
-28.3%
0.01%
-53.8%
Q2 2023$12,620,977
+342.6%
765,836
+146.0%
0.01%
+333.3%
Q1 2023$2,851,416
+15.9%
311,290
-9.4%
0.00%0.0%
Q4 2022$2,461,286
+39.5%
343,755
-2.4%
0.00%
+50.0%
Q3 2022$1,764,000
+5245.5%
352,114
+2521.5%
0.00%
Q2 2022$33,000
-89.8%
13,432
-59.3%
0.00%
Q3 2021$324,000
+252.2%
33,041
+142.3%
0.00%
Q2 2021$92,000
-10.7%
13,636
-33.0%
0.00%
Q3 2020$103,000
-86.8%
20,342
-78.9%
0.00%
-100.0%
Q2 2020$779,000
+628.0%
96,414
+582.9%
0.00%
Q4 2019$107,000
+114.0%
14,118
-19.0%
0.00%
Q2 2019$50,000
+2.0%
17,425
-48.6%
0.00%
Q1 2019$49,000
-58.5%
33,895
-26.1%
0.00%
Q4 2018$118,000
-60.3%
45,844
-32.1%
0.00%
Q3 2018$297,000
-72.1%
67,540
-61.1%
0.00%
-100.0%
Q2 2018$1,065,000
+53.0%
173,661
+81.9%
0.00%0.0%
Q1 2018$696,000
-67.0%
95,462
-62.9%
0.00%
-66.7%
Q4 2017$2,107,000
-21.1%
256,979
+1.1%
0.00%
-25.0%
Q3 2017$2,669,000
-10.1%
254,194
-5.6%
0.00%
-20.0%
Q2 2017$2,969,000
+22.7%
269,141
+7.7%
0.01%
+25.0%
Q1 2017$2,419,000249,8630.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,305,017$18,625,0007.73%
COWEN AND COMPANY, LLC 3,732,778$30,161,0002.74%
GENDELL JEFFREY L 2,446,299$19,766,0001.60%
Asymmetry Capital Management, L.P. 369,134$2,983,0001.58%
Vivo Capital, LLC 2,937,093$23,732,0001.43%
Samsara BioCapital, LLC 659,409$5,328,0001.03%
Altium Capital Management LP 440,589$3,560,0000.98%
Knott David M Jr 258,198$2,086,0000.71%
RTW INVESTMENTS, LP 5,741,939$46,395,0000.68%
FRAZIER MANAGEMENT LLC 951,814$7,691,0000.59%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders